The 20 Best HER-2 Positive Breast Cancer Doctors Near Me in lebanon, NH

Find the Top HER-2 Positive Breast Cancer Experts and Specialists

Last Updated: 09/26/2026

Save doctors for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Already have a doctor?
Find A Second Opinion

MediFind found 1 doctor with experience in HER-2 Positive Breast Cancer near lebanon, NH. Of these, 1 are Experienced.

Location
LocationClose
1 provider found
    Experienced in HER-2 Positive Breast Cancer
    Experienced in HER-2 Positive Breast Cancer
    Referral may be required

    Mary Hitchcock Memorial Hospital

    1 Medical Center Dr, 
    Lebanon, NH 
     (2.7 miles away)
    Languages Spoken:
    English
    Offers Telehealth

    Mary Chamberlin is an Oncologist practicing medicine in Lebanon, New Hampshire. Dr. Chamberlin is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

    Learn about our expert tiers

    To see more doctors, please expand your search radius or view related conditions below.

    Breast Cancer

    Showing 1-1 of 1

    Last Updated: 09/26/2026

    What is the definition of HER-2 Positive Breast Cancer?

    HER2-positive breast cancer is a subtype of breast cancer that contains human epidermal growth factor receptor 2 (HER2), which is a protein that increases the growth of cancer cells. One out of five breast cancers contain the HER2 protein. Eighteen-to-twenty percent of invasive breast cancers are HER2-positive, which are more aggressive than other breast cancers, more likely to spread and relapse, and have resulted in a decreased survival rate in the past. While previously considered to be the most aggressive type of breast cancer, HER-2 positive breast cancer can now be treated with new biologic targeted therapies that have significantly improved outcomes. HER2-positive breast cancer is categorized in stages that take into account the diameter of the tumor, whether the cancer has spread to axillary (underarm) lymph nodes, and whether the cancer has spread to other organs, such as the liver, lung, brain and bone. Staging allows for treatment plans that target each patient’s individual breast cancer disease. Early breast cancers are staged based on the following criteria: Stage 0 – Ductal cancer in situ (DCIS), or a noninvasive breast cancer that is limited to the ducts. Stage I (A/B) – Cancer has spread from ducts to the surrounding fatty breast tissue. Tumor is smaller than 2 centimeters and has not spread to lymph nodes. Stage II (IIA/B) – Cancer has spread from ducts to the surrounding fatty breast tissue and may have spread to near lymph nodes. Tumor is between 2-to-5 centimeters wide. Advanced breast cancers are staged based on the following criteria: Stage III (IIIA/B) – The tumor is larger than 5 centimeters, cancer may or may not have spread to lymph nodes, or the tumor is smaller, and cancer has spread to lymph nodes. Stage IV – Metastatic Breast Cancer. Cancer has spread to lymph nodes and other parts of the body, with other organs affected, such as liver, lungs, brain, or bones.

    More HER-2 Positive Breast Cancer Doctors by city

    15 miles has been selected.